Financhill
Back

BioLineRx Ltd. Stock Predictions

BioLineRx Ltd. Stock Forecast

  • Is BioLineRx Ltd. Stock Undervalued?
    The current BioLineRx Ltd. [BLRX] share price is $2.92. The Score for BLRX is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • BLRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will BioLineRx Ltd. Stock Go Up Next Year?

Data Unavailable

BioLineRx Ltd. Stock Rating

Data Unavailable

BioLineRx Ltd. Stock Price History

Is BLRX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLRX is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Israel
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biolinerx.com

52-Week Data

52-Week High:
14.70
52-Week Low:
2.30

Prediction Charts

Market Cap:
12.7M
Price in USD:
2.92
Volume:
62K
Beta:
1.72

Technical Analysis

SMA50:
3.36
SMA100:
3.59
SMA200:
3.70
52-Wk Change:
-67.06%

Stock Predictions

  • Is BioLineRx Ltd. stock public?
    Yes, BioLineRx Ltd. is a publicly traded company.
  • What is the BioLineRx Ltd. stock quote today?
    The BioLineRx Ltd. stock price is 2.92 USD today.
  • How to buy BioLineRx Ltd. stock online?
    You can buy BioLineRx Ltd. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-8 3.19 3.32 3.43 3.16
Dec-9 3.32 3.25 3.36 3.24
Dec-10 3.30 3.31 3.33 3.16
Dec-11 3.26 3.23 3.29 3.16
Dec-12 3.19 3.31 3.31 3.14
Dec-15 3.22 3.18 3.36 3.17
Dec-16 3.13 3.01 3.17 3.01
Dec-17 3.02 2.98 3.10 2.87
Dec-18 2.99 2.96 3.07 2.90
Dec-19 2.96 3.04 3.10 2.93
Dec-22 3.08 2.88 3.09 2.88
Dec-24 3.00 2.93 3.03 2.90
Dec-26 2.88 2.90 2.96 2.81
Dec-29 2.86 2.92 3.10 2.86

BioLineRx Ltd. Earnings

Data Unavailable

BioLineRx Ltd. Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.00 per share.

* BioLineRx Ltd. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.